Key facts
- This page summarizes Frederick Munsch's Form 3 filing for Bausch Health Companies Inc. (BHC).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2021, 17:29.
Frederick Munsch - 01 Jun 2021 Form 3 Insider Report for Bausch Health Companies Inc. (BHC)
- Reporting relationship
- SVP, Controller and CAO
- Issuer ticker
- BHC
- Reported as of
- 01 Jun 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 Jun 2021, 17:29:59 UTC
- Next SEC filing
- 05 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kirsten O'Donnell, attorney-in-fact for Frederick Munsch
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Frederick Munsch filed Form 3 for Bausch Health Companies Inc. (BHC) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BHC
holding
Common Shares, No Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,172
- Date
- 01 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BHC
holding
Derivative
Non-Qualified Stock Options (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 8,046
- Exercise price
- $14.38
- Footnotes
- F3
BHC
holding
Derivative
Non-Qualified Stock Options (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 12,172
- Exercise price
- $15.32
- Footnotes
- F3
BHC
holding
Derivative
Non-Qualified Stock Options (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 8,506
- Exercise price
- $23.16
- Footnotes
- F3
BHC
holding
Derivative
Non-Qualified Stock Options (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 11,265
- Exercise price
- $24.77
- Footnotes
- F3
BHC
holding
Derivative
Non-Qualified Stock Options (right to purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 6,683
- Exercise price
- $32.56
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 14,616 Restricted Share Units ("RSUs") which will vest, subject to the reporting person's continued service, as follows: (i) 891 RSUs on February 26, 2022; (ii) 974 RSUs on February 27, 2022; (iii) 892 RSUs on February 26, 2023; (iv) 5,322 RSUs granted on March 3, 2021 that will vest in equal installments on each of the first three anniversaries of the date of grant; and (v) 6,537 RSUs granted on May 3, 2021 that will vest in equal in equal installments on each of the first three anniversaries of the date of grant.
Footnote F2
Vested RSUs are settled in Common Shares, no par value, of the Issuer.
Footnote F3
Vests in equal installments on each of the first three anniversaries of the date of grant.